Anzeige
Novara — A Smarter Way to Access Global Markets
LIVE-DESK·Globale Marktredaktion

Aktien

Kimberly Boynton Joins NBT Bancorp Board as Healthcare and Real Estate Expert
AktienArticle

Kimberly Boynton Joins NBT Bancorp Board as Healthcare and Real Estate Expert

NBT Bancorp Inc. announced Kimberly A. Boynton’s appointment to its board of directors, bringing over two decades of executive experience in healthcare, finance, and commercial real estate.

Priya Anand · 21 Sept 2026
Industrial Logistics Properties Trust Names Anthony Paula as New CFO
AktienArticle

Industrial Logistics Properties Trust Names Anthony Paula as New CFO

RMR Group executive replaces Tiffany Sy at industrial logistics REIT; transition takes effect Oct. 1 amid portfolio expansion across 39 states.

Priya Anand · 21 Sept 2026
Taltson Critical Minerals appoints CFO, raises $85,000 in private placement
AktienArticle

Taltson Critical Minerals appoints CFO, raises $85,000 in private placement

The Vancouver‑based explorer named Casey Forward as chief financial officer and closed a $85,000 non‑brokered private placement of 2.125 million units, with an insider buying 23.5% of the issue.

Priya Anand · 21 Sept 2026
PACS Group Appoints Patrick Murphy as New Chief Legal Officer
AktienArticle

PACS Group Appoints Patrick Murphy as New Chief Legal Officer

Patrick Murphy takes over as Chief Legal Officer and Corporate Secretary, succeeding John Mitchell who retired after 15 years at the company.

Priya Anand · 21 Sept 2026
Roche receives EU approval for Susvimo, eyeing new market opportunities
AktienArticle

Roche receives EU approval for Susvimo, eyeing new market opportunities

Pharmaceutical giant Roche has obtained EU approval for its eye medication Susvimo, opening up new sales channels and bringing the stock back into focus.

Priya Anand · 21 Sept 2026
Vireo Growth acquires Nevada dispensary for $500K in cash and shares
AktienArticle

Vireo Growth acquires Nevada dispensary for $500K in cash and shares

Minneapolis-based Vireo Growth completed a $500,000 acquisition of M3 Wellness in Nevada, paying $290,000 in cash and issuing subordinate voting shares at a $15.12 valuation.

Priya Anand · 21 Sept 2026
Nyxoah appoints interim CFO, reaffirms 2026 revenue and margin guidance
AktienArticle

Nyxoah appoints interim CFO, reaffirms 2026 revenue and margin guidance

Nyxoah SA said President International Loïc Moreau will serve as interim chief financial officer after John Landry's departure on Oct. 2, and confirmed its 2026 revenue, margin and expense targets.

Priya Anand · 21 Sept 2026
Vicor Raises Q3 Revenue Guidance on Licensing Royalties
AktienArticle

Vicor Raises Q3 Revenue Guidance on Licensing Royalties

Andover-based Vicor Corporation boosted its third-quarter revenue outlook by more than a decade, citing royalties from a recent licensing deal on its Vertical Power Delivery technology.

Priya Anand · 21 Sept 2026
Qnity Electronics Added to PHLX Semiconductor Sector Index
AktienArticle

Qnity Electronics Added to PHLX Semiconductor Sector Index

The Wilmington-based chip maker joins the benchmark index tracking the 30 largest eligible U.S. semiconductor companies, following its NYSE listing.

Priya Anand · 21 Sept 2026
Toro adds Tennant CEO David Huml to board of directors
AktienArticle

Toro adds Tennant CEO David Huml to board of directors

The Toro Company appointed David Huml, chief executive of Tennant, to its board effective immediately, citing his expertise in robotics and smart‑connected technologies.

Priya Anand · 21 Sept 2026
Travere Therapeutics Names CEO Bradley Campbell to Succeed Eric Dube
AktienArticle

Travere Therapeutics Names CEO Bradley Campbell to Succeed Eric Dube

Eric Dube steps down as CEO on December 1, with Campbell taking over after a board-led search for a successor focused on rare kidney disease therapies.

Priya Anand · 21 Sept 2026
CVRx Names John Landry as New CFO, Succeeding Oasheim
AktienArticle

CVRx Names John Landry as New CFO, Succeeding Oasheim

John Landry, former CFO of Nyxoah SA, will take over as chief financial officer of CVRx starting October 12, 2026, following Jared Oasheim’s transition.

Priya Anand · 21 Sept 2026
Novartis Q1 Revenue Falls 1% as Generics Erode Drug Market Share
AktienArticle

Novartis Q1 Revenue Falls 1% as Generics Erode Drug Market Share

Pharmaceutical giant Novartis reported a first-quarter revenue decline of 1% and a 12% drop in core operating profit, driven by patent expirations and intensified generic competition.

Priya Anand · 21 Sept 2026
Nestlé, Novartis, Roche and UBS: What Moves Switzerland’s Biggest Stocks?
AktienArticle

Nestlé, Novartis, Roche and UBS: What Moves Switzerland’s Biggest Stocks?

Switzerland may be a relatively small country, but its stock market contains companies with enormous global influence.

Scinai Regains Nasdaq Compliance After 19-Day Bid Price Hold
AktienArticle

Scinai Regains Nasdaq Compliance After 19-Day Bid Price Hold

Scinai Immunotherapeutics Ltd. returned to full compliance with Nasdaq’s minimum bid price rule after a 19-day period of adherence, following a prior violation in March.

Priya Anand · 21 Sept 2026
FDA grants platform technology designation to Precigen's AdenoVerse
AktienArticle

FDA grants platform technology designation to Precigen's AdenoVerse

The U.S. FDA has awarded platform technology status to Precigen's AdenoVerse immunotherapy platform, which underpins the approved PAPZIMEOS treatment and several HPV‑related cancer studies.

Priya Anand · 21 Sept 2026
Latam Lithium to hold shareholder vote on 3-for-1 consolidation
AktienArticle

Latam Lithium to hold shareholder vote on 3-for-1 consolidation

Latam Lithium Corp. has scheduled an annual general and special meeting for October 22, 2026, to vote on a three-for-one share consolidation, which will reduce the number of outstanding shares from approximately 35.3 million to 11.8 million.

Priya Anand · 21 Sept 2026
SEC’s Tokenized Stock Rules Face TD Cowen’s Skepticism on Adoption
AktienArticle

SEC’s Tokenized Stock Rules Face TD Cowen’s Skepticism on Adoption

The SEC’s new framework for tokenized stock trading may not spur near-term demand, as investors already have efficient access to traditional markets, analysts warn.

Priya Anand · 21 Sept 2026
Moderna Stock Hits 52‑Week High at $176.75
AktienArticle

Moderna Stock Hits 52‑Week High at $176.75

The biotech firm’s shares rose to their yearly peak amid strong vaccine‑related developments, a $2 billion convertible notes offering and mixed analyst ratings, while its market cap stands near $70.4 billion.

Priya Anand · 21 Sept 2026
US Stocks Rise on Oil Price Decline, Nasdaq 100 Hits 3-Month High
AktienArticle

US Stocks Rise on Oil Price Decline, Nasdaq 100 Hits 3-Month High

US stock markets saw significant gains on Monday, supported by hopes for diplomatic progress in the Middle East and falling oil prices. The Nasdaq 100 reached its highest level in three months.

Priya Anand · 21 Sept 2026
Ethan Allen faces proxy battle over CEO succession process
AktienArticle

Ethan Allen faces proxy battle over CEO succession process

Activist shareholder Doug Bergeron challenges board’s succession plan, seeking independent CEO search and director nominees

Priya Anand · 21 Sept 2026
Post Holdings Shares Hit 52-Week Low as Analysts Cut Forecasts
AktienArticle

Post Holdings Shares Hit 52-Week Low as Analysts Cut Forecasts

Cereal maker's stock fell to $75.38, down 36% from its 52-week high, after five analysts revised earnings estimates lower despite a solid third quarter.

Priya Anand · 21 Sept 2026
Seven Steps to Successful Investment: A Guide for Beginners
AktienArticle

Seven Steps to Successful Investment: A Guide for Beginners

A seven-step guide to investing and building wealth, suitable for beginners and experienced investors alike. Learn how to define goals, assess risk tolerance, and choose the right investment instruments.

Priya Anand · 21 Sept 2026
Kromek’s Shares Drop Amid Revenue Shift as Non-Licensed Business Expands
AktienArticle

Kromek’s Shares Drop Amid Revenue Shift as Non-Licensed Business Expands

Kromek Group plc’s shares fell on Tuesday as the AIM-listed company reported a revenue mix shift toward non-licensed business, with growth in photon-counting CT and SPECT imaging driving a 112% forecast rise in non-licensed revenue by FY 2027.

Priya Anand · 21 Sept 2026